GeminIQ

NEOG

NEOGEN CORP
$12.55previous close on: 9/16/2026

Company Information

Company Name
NEOGEN CORP
CIK
CIK0000711377
Category
Large accelerated filer
Ticker: Exchange
NEOG: Nasdaq
Fiscal Year End
May 31
Owner Organization
03 Life Sciences
SIC
2835
SIC Description
In Vitro & In Vivo Diagnostic Substances
Ticker
NEOG

SEC filing data through

Insider Sentiment

Last purchase
2026-02-17
Last sale
2023-10-13
Shares purchased (TTM)
117,817
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
212,199,260
Shares outstanding
217,668,392
Ownership
97.49%
-15.74% Y/Y

Earnings Market Reaction

Filing date
2026-07-30
Price on filing date
—
1-month reaction
Pending
3-month reaction
Pending
Drift continued3/11 (27%)
Faded / reversed8/11 (73%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-312024-05-312024-02-292023-11-302023-08-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value186160145139129128140120171161206179
Marketable Securities Current----0000072560
Accounts Receivable Net Current147137132138153160164168173174150138
Inventory Net
Inventory Raw Materials-565867-757577----
Inventory Work In Process-91112-141413----
Inventory Finished Goods-113109132-136128126----
Inventory Gross-178177210-226218216----
Inventory Valuation Reserves--17-15-17--20-20-17----
Inventory Net144162163193191205198199189182161141
Prepaid Expense And Other Assets Current606358535358685456788366
Assets Of Disposal Group Including Discontinued Operation Current686877050---0---
Assets Current605590575524577552570541589602624584
Property Plant And Equipment Net
Land And Land Improvements11---11---10---
Buildings And Improvements Gross234---109---108---
Machinery And Equipment Gross159---181---176---
Furniture And Fixtures Gross7---8---8---
Construction In Progress Gross70---186---114---
Property Plant And Equipment Gross480---495---417---
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment-151----155----140---
Property Plant And Equipment Net330332332346339328311301277272244221
Other Assets Noncurrent
Operating Lease Right Of Use Asset171615171717171415151515
Goodwill1,0471,0481,0461,0661,0651,6721,6732,1372,1362,1362,1382,138
Intangible Assets Net Excluding Goodwill-----1,4391,4631,490-1,5401,5651,588
Finite Lived Intangible Assets Net1,3181,3421,3591,3891,411---1,512---
Other Assets Noncurrent303233363529202020161616
Other Assets2,4122,4372,4532,5082,528---3,682---
Assets3,3463,3593,3603,3783,4444,0364,0544,5034,5494,5824,6024,561
Liabilities Current
Finance Lease Liability Current-000-3332333
Long Term Debt Current0---19---2---
Accounts Payable Current7975637780728061839011290
Employee Related Liabilities Current272420201418161620201615
Accrued Income Taxes Current7109961311111012105
Interest Payable Current114114113114113113
Deferred Revenue Current444666665554
Other Accrued Liabilities Current---------252018
Other Liabilities Current242831313226252223---
Liabilities Of Disposal Group Including Discontinued Operation Current76907-------
Liabilities Current158151147146174141151123154158177138
Deferred Income Tax Liabilities Net258269274277281301302318327354355355
Long Term Debt Noncurrent794793793793875891890889888888887886
Other Liabilities Noncurrent444442444343423935373636
Liabilities1,2531,2571,2551,2601,3731,3761,3851,3681,4051,4361,4551,415
Stockholders Equity
Preferred Stock Value---0-0000000
Common Stock Value353535353535353535353535
Additional Paid In Capital2,6162,6132,6112,6072,6022,5982,5922,5892,5842,5802,5752,572
Accumulated Other Comprehensive Income Loss Net Of Tax-14-13-26-23-29-48-45-31-30-29-25-26
Retained Earnings Accumulated Deficit-544-533-516-500-5367687543556561563567
Stockholders Equity2,0932,1022,1042,1192,0712,6602,6693,1353,1443,1463,1483,146
Liabilities And Stockholders Equity3,3463,3593,3603,3783,4444,0364,0544,5034,5494,5824,6024,561
Trading Securities Debt Amortized Cost--------0---
Allowance For Doubtful Accounts Receivable Current-445-554-433
Preferred Stock Par Or Stated Value Per Share1.001.001.001.001.001.001.001.001.001.001.001.00
Preferred Stock Shares Authorized000000000000
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.160.160.160.160.160.160.160.160.160.160.160.16
Common Stock Shares Authorized315315315315315315315315315315315315
Common Stock Shares Issued218218218217217217217217217217217216
Shares Outstanding218218218217217217217217217217217216

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

NEOGEN CORP (NEOG) — SEC Financial Statements & Analysis

NEOGEN CORP (NEOG) is a in vitro & in vivo diagnostic substances company, incorporated in MI. NEOGEN CORP trades on Nasdaq as: NEOG. NEOGEN CORP (NEOG)'s most recent SEC filing is a Form 10-K for the period ended 2026-05-31, filed with the SEC on 2026-07-30. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), NEOGEN CORP carries a market cap of $1.95B, a P/E ratio of -246.96x, a P/B ratio of 0.93x, a P/S ratio of 2.24x, an enterprise value of $2.56B, and an EV/EBITDA multiple of 27.02x. On profitability, it posts a gross margin of 46.93%, an operating margin of -2.48%, a net margin of -0.91%, a Return on Equity (ROE) of -0.38%, a Return on Assets (ROA) of -0.23%, and a Return on Invested Capital (ROIC) of -0.68%. Per share, it reports EPS of $-0.04, diluted EPS of $-0.04, free cash flow per share of $0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.72% year-over-year, net income growth of -99.28% year-over-year, and EPS growth of -99.28% year-over-year. On the balance sheet, it maintains a current ratio of 3.82x, a quick ratio of 2.53x, working capital of $446.40M, a debt-to-equity ratio of 0.60x, a debt ratio of 0.37, free cash flow of $31.90M (TTM), and net debt of $608.20M. Figures sourced from SEC EDGAR.

Market Cap
$1.95B
P/E TTM
-246.96x
EPS TTM
$-0.04
P/B TTM
0.93x
ROE TTM
-0.38%
ROA TTM
-0.23%
Debt To Equity
0.60x
Free Cash Flow TTM
$31.90M
Net Revenue TTM Growth 1Y
-2.72%

Data as of 2026-05-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEOGEN CORP in?

NEOGEN CORP (NEOG) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What exchange does NEOG trade on?

NEOGEN CORP (NEOG) trades on the Nasdaq.

Where is NEOGEN CORP incorporated?

NEOGEN CORP is incorporated in MI.

When was NEOGEN CORP (NEOG)'s most recent SEC filing?

NEOGEN CORP (NEOG)'s most recent SEC filing is a Form 10-K for the period ended 2026-05-31, filed with the SEC on 2026-07-30.

What is NEOG's market cap?

NEOGEN CORP (NEOG) has a market capitalization of $1.95B as of 2026-05-31.

What is NEOG's EPS (earnings per share)?

NEOGEN CORP (NEOG)'s trailing twelve month EPS is $-0.04 as of 2026-05-31.

What is NEOG's ROE (return on equity)?

NEOGEN CORP (NEOG)'s trailing twelve month Return on Equity (ROE) is -0.38% as of 2026-05-31.

What is NEOG's ROA (return on assets)?

NEOGEN CORP (NEOG)'s trailing twelve month Return on Assets (ROA) is -0.23% as of 2026-05-31.

What is NEOG's ROIC (return on invested capital)?

NEOGEN CORP (NEOG)'s trailing twelve month Return on Invested Capital (ROIC) is -0.68% as of 2026-05-31.

What is NEOG's EV/EBITDA?

NEOGEN CORP (NEOG)'s trailing twelve month EV/EBITDA is 27.02x as of 2026-05-31.

Wall Street's data.
Main Street's price.

Start 7-day free trial